Is SUVmax Helpful in the Differential Diagnosis of Enlarged Mediastinal Lymph Nodes? A Pilot Study

Table 1

Patient characteristic of 94 patients.

Variable	No.
Age
Range	7–85 y
Median	50 y
Sex
Male	62
Female	32
Follow-up time (d)
Range	43–1100
Median	462
Pathologic diagnosis	No. patients	Age (y) (range/median)	Male/female
Benign pathology	42	18–85/52	21/21
Sarcoidosis	16	28–57/50	6/10
Tuberculosis	17	19–75/50	10/7
Lymphadenitis	8	18–85/65	4/4
CD	1	53	1/0
Malignant pathology	52	7–78/47	41/11
Lymphoma	25	7–78/34	21/4
Metastatic lymph nodes	26	23–71/58	20/6
AL	1	64	0/1

CD: Castleman disease; AL: acute leukemic.